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ABSTRACT 34 
The use of cell factories for the production of bulk and value-added compounds is 35 
nowadays an advantageous alternative to the traditional petrochemical methods. 36 
Nevertheless, the efficiency and productivity of several of these processes can improve 37 
with the implementation of micro-oxic or anoxic conditions. In the industrial setting, 38 
laccases are appealing catalysts able to oxidize a wide range of substrates and reduce O2 to 39 
H2O. In this work, several laccase-based devices were designed and constructed foreseeing 40 
the modulation of intracellular oxygen concentration in bacterial chassis. These Oxygen 41 
Consuming Devices (OCDs) included Escherichia coli’s native laccase (CueO) and three 42 
variants of this protein obtained by directed evolution. The OCDs were initially 43 
characterized in vitro using E. coli DH5α protein extracts, and subsequently using extracts 44 
obtained from other E. coli strains and in vivo. Upon induction of the OCDs no major effect 45 
on growth was observed in four of the strains tested, and the analysis of the cell extracts 46 
protein profiles revealed increased levels of laccase. Moreover, oxygen consumption 47 
associated to the OCDs occurred in all conditions tested but the performance of the device 48 
was shown to be strain-dependent, highlighting the importance of the genetic background 49 
even in closely related strains. One of the laccase variants showed a 13- and 5-fold increase 50 
in oxidase activity and O2 consumption rate, respectively. Furthermore, it was also possible 51 
to demonstrate O2 consumption in vivo using L-DOPA as substrate, which represents the 52 
proof of concept that these OCDs generate an intracellular oxygen sink thereby 53 
manipulating the redox status of the cells. In addition, the modularity and orthogonality 54 
principles used for the development of these devices allow an easy reassembly and fine-55 
tuning foreseeing their introduction into other chassis/systems. 56 
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INTRODUCTION 59 
Micro-oxic and anoxic environments are fundamental to numerous processes with 60 
significance to clinical, environmental, and industrial fields. It is generally accepted that 61 
hypoxia is established during infectious processes1-3 and that hypoxia inducible factors are 62 
central regulators of tumor phenotype contributing to malignancy.4 Likewise, micro-oxic 63 
and anoxic processes are critical for maintenance of carbon, nitrogen and sulfur global 64 
cycles, the degradation of recalcitrant organic compounds or transformation of metals and 65 
metalloids to less toxic forms.5,6 In industrial biotechnology, the applications in oxygen 66 
limited conditions have been largely overlooked compared to their counterparts in oxic 67 
conditions. Although ethanol, butanol, malate or polyhydroxybutyrate can be produced 68 
under micro-oxic or anoxic conditions,7-10 the shift from fossil-based to biobased economy 69 
will benefit from an increased implementation of processes for biomass valorization or the 70 
synthesis of energy carriers, biofuels, bulk chemicals, probiotics, or bioactive compounds 71 
under O2-limited conditions.6 Currently, the production of many chemicals/compounds by 72 
aerobic processes has low productivity since cell metabolism favors biomass formation.10,11 73 
The presence of O2 can also negatively affect processes by enzyme inhibition, for e.g., the 74 
photobiological production of H2 is severely compromised by the presence of oxygen due 75 
to the sensitivity of the H2-evolving enzymes: hydrogenases and nitrogenases.12,13 76 
Therefore, the development of micro-oxic/anoxic processes is highly desirable to achieve 77 
high efficiencies and near theoretical yields.11 In this context, several strategies were 78 
successfully implemented to increase the production of propanol, butanol, or ethanol in 79 
Escherichia coli 14-20 and synthetic biology has played a significant role in the development 80 
of these metabolic engineering approaches with the redesign of existing pathways or the de 81 
novo design.21,22 82 
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In an industrial setting, laccases are considered green catalysts due to the wide range 83 
of substrates catalyzed without the need for co-factors or production of toxic peroxide 84 
intermediates.23,24 Laccases belong to the multicopper oxidase protein superfamily that is 85 
characterized by the highly conserved copper binding motifs: the T1 mononuclear copper 86 
center (where the one-electron substrate oxidation occurs), and the T2/T3 trinuclear copper 87 
center that catalyzes the four-electron reduction of oxygen to water.25,26 The applications 88 
based on these enzymes are broad, ranging from paper, food and textile industries to 89 
bioremediation, biosensors, cosmetics, and organic synthesis.23,27,28 Fungal laccases are 90 
often used for these purposes, but recently the interest in proteins from bacterial origin is 91 
increasing due to their higher thermal and pH stability. Moreover, the latter are more prone 92 
to activity and specificity improvements through protein engineering.23 E. coli’s native 93 
multicopper oxidase (CueO) is a monomeric periplasmic protein involved in copper 94 
homeostasis.29 Besides the characteristic copper binding motifs, CueO displays a 95 
methionine rich insert which provides extra copper binding sites that are essential for the 96 
cuprous oxidase activity related to copper detoxification, the physiological function 97 
recently attributed to the protein.26,30 In addition, CueO also exhibits significant laccase 98 
(phenol oxidase) activity with broad substrate specificity. Taking advantage of this feature, 99 
several OCDs - Oxygen Consuming Devices based on the CueO laccase were assembled 100 
following the standardization and modularity principles and envisaging the modulation of 101 
the intracellular oxygen concentration in bacterial chassis. These OCDs were tested in vitro 102 
in different conditions and in different E. coli genetic backgrounds, and the proof of 103 
concept for the in vivo modulation of intracellular oxygen using these OCDs is also 104 
provided. Moreover, the approach followed here will allow extending the use of OCDs to 105 
other organisms/chassis, enabling the development of bioprocesses such as bioremediation 106 
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or production of biofuels and the elucidation of fundamental aspects of adaptation to 107 
oxygen limited/deprived conditions. 108 
 109 
RESULTS AND DISCUSSION 110 
Selection of Targets, Design and Assembly of the Lac OCD. Aiming at modulating the 111 
intracellular O2 concentration in bacterial chassis commonly used in industrial processes, a 112 
bioinformatics tool (DESHARKY)31 was used to identify metabolic routes involving the 113 
oxidation of natural compounds (metabolites) and consequent O2 consumption. The search 114 
was based on a Monte Carlo heuristic algorithm, considering E. coli and Synechocystis sp. 115 
PCC 6803 as hosts, and O2 as reactant source. From the tool outputs, the pathways 116 
comprising enzymes without information available in KEGG were eliminated and it was 117 
also imposed that the substrates for these reactions should be present in the hosts. 118 
Moreover, among pathways containing cycles of oxygen production-degradation, it was 119 
checked that the pathway effective stoichiometry involved the consumption of oxygen. 120 
Based on this search, several oxygen consuming devices were designed and tested (e.g. A-121 
type flavoproteins, glucose oxidase) however, based on preliminary results and various 122 
technical difficulties that have arisen only the characterization of the OCDs based on E. 123 
coli’s K-12 native laccase (CueO) is presented here. 124 
Envisaging the introduction of the OCDs in different bacteria, the 1551 bp sequence 125 
of cueO ORF was codon-optimized considering the codon usage of E. coli K-12, 126 
Synechocystis sp. PCC 6803 and Nostoc sp. PCC 7120 to obtain a single sequence that 127 
could be expressed in the three organisms – cueO*. Comparison of the codon adaptiveness 128 
of the codon optimized and original cueO ORFs (Figure S1) revealed significant codon 129 
usage differences, with 27% of the codons showing codon usage differences above 50%. 130 
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For an approximate indication of the likely success of the codon optimized sequence 131 
expression in E. coli, the codon adaptation index (CAI) was calculated; since this index is a 132 
measurement of the relative adaptiveness of the codon usage of a gene towards the codon 133 
usage of highly expressed genes.32 The original and codon-optimized cueO sequences 134 
showed similar CAI values, (0.816 and 0.782, respectively) indicating that the synthetic 135 
sequence would most likely be expressed in E. coli, despite the codon alterations made. 136 
Successful expression is also expected in Synechocystis sp. PCC 6803 and Nostoc sp. PCC 137 
7120 since the CAI indexes obtained were 0.767 and 0.785, respectively. In addition to the 138 
codon-optimized cueO ORF (cueO*), the synthetic DNA sequence includes the RBS 139 
BBa_B0034, double stop codons (TAATAA), and the prefix and suffix sequences of the 140 
BioBrick RFC[10] standard.33 Subsequently, this sequence was cloned downstream the 141 
F2620 BioBrick originating the laccase-based OCD – Lac OCD (Figure 1). The F2620 142 
BioBrick is a regulatory element that enables the device induction upon addition of 143 
signaling molecules of the acyl-homoserine lactone family (AHLs). 144 
 145 
146 
Figure 1. Schematic representation of the laccase based Oxygen Consuming Device (Lac OCD). The 147 
device includes the RBS B0034, the codon optimized cueO ORF (cueO*) with double stop codons 148 
(TAATAA) followed by the double terminator B0015 and is regulated by the F2620 BioBrick. This 149 
regulatory element enables OCD regulation by the PluxR promoter that is activated by the complex formed 150 
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between signaling molecules of the acyl-homoserine lactone class (AHLs) and the LuxR protein. The luxR 151 
ORF is preceded by the RBS B0034 and the constitutive promoter PtetR. The Lac OCD is flanked by the 152 
BioBrick (BB) prefix (with the EcoRI (E) and the XbaI (X) restriction sites) and the BB suffix (with SpeI (S) 153 
and PstI (P) restriction sites) and is in a BioBrick backbone, the pSB1A3 that harbors the gene conferring 154 
resistance to Ampicillin. 155 
 156 
Effect of Laccase OCD Activation on Growth and Protein Profiles of Five E. coli 157 
Strains. It is widely recognized that the performance of synthetic parts is dependent on the 158 
genomic and metabolic context.34,35 Therefore the Lac OCD was introduced and 159 
characterized in different E. coli strains routinely used in laboratory: DH5α, BL21(DE3), 160 
MG1655, SURE and Top10. In addition to the strains containing the Lac OCD, control 161 
strains harboring the plasmid with the F2620 BioBrick (F2620) only were also generated. 162 
The growth of the E. coli strains (DH5α, BL21(DE3), MG1655, SURE and 163 
Top10) containing the F2620 only or the F2620 plus the Lac OCD (Lac OCD) was 164 
compared to the respective wild-type, in absence/presence of the inducer AHL (N-(β-165 
ketocaproyl)-L-homoserine lactone, 3OC6HSL). No significant differences in growth were 166 
observed, except for the SURE and DH5α strains (Figure 2a and S2). In the E. coli SURE 167 
strain, a premature onset of the stationary phase was observed in the wild-type and cells 168 
harboring the Lac OCD while for cells harboring the F2620 the growth was unstable 169 
(Figure S2). This reduced fitness may be due to the strain’s impaired DNA repair, 170 
recombination and restriction systems. For E. coli DH5α, the cells containing the Lac OCD 171 
showed hindered growth in the 6 hours that followed the addition of AHL (Figure 2a), with 172 
a decrease in growth rate to 36% (0.12 h-1) of the wild-type rate (0.35 h-1). However, after 173 
this period, the growth behavior was similar to the wild-type. Previous studies report that 174 
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metabolic burden leads to growth alterations that can be related to the reallocation of cell’s 175 
resources to maintain the plasmid used to transform cells,36 which is not the case here since 176 
no differences in growth were observed between the wild-type and the cells harboring the 177 
F2620. 178 
 179 
180 
Figure 2. Effect of the Lac OCD activation on E. coli DH5α growth (a) and protein profiles (b). For the 181 
growth experiment (a) the wild-type (wt), the cells containing the F2620 only or the F2620 plus the Lac OCD 182 
(Lac OCD) were grown in absence (C) or presence of the inducer (AHL). Growth was monitored measuring 183 
the OD600 every 2 hours for a 24 hour period. Error bars represent the standard deviation of biological 184 
replicates (n = 3). Protein extracts obtained from E. coli DH5α cultures harboring the F2620 and the F2620 185 
plus the Lac OCD (Lac OCD), in presence (+) or absence (-) of AHL and collected at different time-points 186 
after OCD induction (6, 12 and 24 h) were separated by electrophoresis on SDS-PAGE and stained with 187 
Coomassie Blue (b). The protein band corresponding to the laccase (CueO*) is highlighted by the black 188 
arrow. MW – low molecular weight protein marker (GE Healthcare). 189 
 190 
Increased protein expression can also lead to metabolic burden due to the depletion 191 
of aminoacyl-tRNAs or amino acid pools that are known to be dependent on the growth 192 
rate.36,37 Therefore, DH5α cells containing the Lac OCD and grown in presence or absence 193 
of AHL were collected 6, 12, and 24 hours after induction and the protein profiles were 194 
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visualized on Coomassie blue stained SDS polyacrylamide gels (Figure 2b). In contrast 195 
with the F2620 transformants, a substantial amount of laccase was readily observed in 196 
extracts obtained from cultures harboring the device, particularly in the presence of the 197 
AHL inducer. The highest levels of laccase were observed 6 hours after induction. In the 198 
subsequent points, although the protein levels decrease, laccase was still easily observed. 199 
Therefore, our results suggest that the overexpression of laccase leads to a growth delay in 200 
DH5α cells. The subsequent reduction in protein levels may alleviate the metabolic burden 201 
allowing the recovery of the growth rate after 6 hours, being the culture final OD similar to 202 
the wild-type. 203 
Additionally, the protein profiles of the other E. coli strains (BL21, MG1655, SURE 204 
and Top10) were also analyzed (Figure 3). Similarly to DH5α, a marked difference 205 
between the protein profiles of the cells harboring F2620 or the F2620 plus the Lac OCD 206 
was observed, with increased laccase levels in extracts obtained from cells harboring the 207 
device and grown in presence of the inducer (Figure 3, arrowheads). In the protein profiles 208 
of cells containing the OCD but in absence of AHL, increased levels of laccase could also 209 
be observed compared to the extracts of cells with F2620, suggesting read through from 210 
PtetR or leakiness of the PluxR promoter. This leaky behavior was previously reported to be 211 
dependent both on abiotic and genetic factors such as temperature, media, chassis’ genetic 212 
background or the embedded sequence context.38 For the E. coli strain MG1655 an 213 
inconsistent behavior was registered, as frequently no induction of laccase expression was 214 
observed. 215 
 216 
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 217 
Figure 3. Coomassie stained SDS-PAGE of the protein profiles of different E. coli strains. Protein extracts 218 
were obtained from E. coli BL21, MG1655, SURE and Top10 cultures harboring the F2620 or the F2620 plus 219 
the Lac OCD (Lac OCD), in presence (+) or absence (-) of AHL, collected 6 hours after induction. The 220 
protein band corresponding to the laccase (CueO*) is highlighted by the black arrow, and for each strain the 221 
induced protein expression is highlighted by the black arrowheads. MW – low molecular weight protein 222 
marker (GE Healthcare). 223 
 224 
In sum, the Lac OCD was consistently expressed in four of the five E. coli strains 225 
tested and its activation had only a transient impact on the growth of one of the strains. 226 
Moreover, the device was shown to be robust since increased levels of laccase could still be 227 
detected 24 hours after the induction, in agreement with previous reports on CueO’s high 228 
stability.39 229 
 230 
In Vitro Performance of the Laccase OCD in E. coli DH5α. An extensive 231 
characterization of the Lac OCD was carried out in E.coli DH5α to determine the dynamic 232 
range of the device performance. For this purpose, phenol oxidase activity and O2 233 
consumption rates were determined using protein extracts obtained from cells induced in 234 
exponential or stationary phase, and grown in M9 minimal medium or M9 supplemented 235 
with copper. In addition, cells were collected at different time-points: 6, 12 or 24 hours 236 
after AHL induction. The influence of the different parameters on the OCD performance 237 
was statistically determined performing a four-way ANOVA, where a model with all the 238 
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effects and interactions up to the third order was tested. The statistical analysis revealed 239 
that the medium used for cell growth does not influence the device performance in terms of 240 
laccase activity or O2 consumption (p-value = 2.20x10-02 and 6.78x10-02, respectively). For 241 
this reason, the results obtained using M9 medium supplemented with copper (Figure 4) 242 
were shown separately from those obtained with M9 medium (Figure S3). Although the 243 
time of induction was shown to have an influence in the Lac OCD, with a significant p-244 
value of 2.36x10-05, the impact of this parameter is modest (with a partial Eta squared value 245 
of 0.062). The growth phase in which the device was induced showed to have an impact on 246 
the performance (p-value = 1.97x10-19), with cells grown in M9 medium and induced in 247 
stationary phase showing higher O2 consumption rates than cells induced in exponential 248 
phase (Figure S3b and d). Even though the Lac OCD was partly active in absence of AHL, 249 
as expected the statistical analysis revealed that the presence of the inducer has the most 250 
influence in performance, with significant p-values of 2.13x10-30 for laccase activity and 251 
2.29x10-23 for O2 consumption. In fact, compared to the other factors (growth phase or time 252 
of induction), a clear on-off switching effect of the inducer can be easily observed for most 253 
conditions tested (Figure 4 and Figure S3). 254 
 255 
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 256 
Figure 4. Characterization of the Lac OCD in E. coli DH5α cells grown in M9 medium supplemented with 257 
Cu2+. Specific laccase activity (a and c) and O2 consumption rate measurements (b and d) were performed 258 
using protein extracts obtained from cultures harboring the F2620 or the F2620 plus the Lac OCD (Lac 259 
OCD). Cultures were induced in exponential (top panel) or stationary phase (lower panel) and collected 6, 12 260 
and 24 hours after induction. Cells were grown in the absence of inducer (control) or with 10 µM AHL 261 
(induced). The fold increase in O2 consumption (induced Lac OCD vs. induced F2620) at 6, 12 or 24 hours 262 
after induction is shown in b and d. Results were normalized per µg of protein. Error bars represent the 263 
standard deviation of biological replicates (n = 3). 264 
 265 
This in vitro characterization of the Lac OCD revealed that this is a robust device 266 
able to consume O2 in all the conditions tested. Furthermore, O2 consumption rates were 267 
found to increase 10- to 58-fold in cells harboring the Lac OCD compared to cells 268 
harboring the F2620 only (Figure 4 and Figure S3). 269 
Page 13 of 33
ACS Paragon Plus Environment
ACS Synthetic Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
14 
 
In Vitro Performance of the Laccase OCD in Other Genetic Backgrounds. The in vitro 270 
characterization of the Lac OCD was also carried out in other E. coli strains to evaluate the 271 
performance of the device in different genetic backgrounds. For this purpose, protein 272 
extracts obtained from cells grown in M9 Cu2+, induced in exponential phase and harvested 273 
6 hours after induction were used. For E. coli DH5α, BL21, SURE, and Top10, the addition 274 
of AHL led to the consistent activation of the OCD; while for the MG1655 strain, the 275 
device behavior was erratic, with most protein extracts showing no laccase activity. This is 276 
in agreement with our previous experiments, and yet unexpected since the F2620 BioBrick 277 
was reported to be functional in E. coli MG1655 using AHL as inducer.33 The functionality 278 
of the F2620 BioBrick was assessed, replacing the cueO* ORF in the OCD by the gfp ORF 279 
(BBa_E0040). This device was introduced into MG1655 and, for all the biological 280 
replicates tested, the expression of Gfp was detected after the addition of the AHL inducer 281 
(Figure S4), confirming the functionality of the regulatory element in this E. coli strain. In 282 
addition, the OCD was reassembled with the Ptrc1O promoter34, reintroduced and tested in 283 
MG1655, showing consistent laccase activity (Figure S5). However, we were not able to 284 
obtain consistent laccase activity when cueO* is under the regulation of the F2620. This 285 
may be due to the device secondary structure that may interfere with transcription or, since 286 
CueO is a native protein from E. coli, the high expression levels achieved with the F2620 287 
Biobrick in MG1655 may trigger a regulatory mechanism (e.g. degradation). Therefore, the 288 
behavior of the Lac OCD regulated by the F2620 BioBrick was compared only in the other 289 
four strains (Figure 5). 290 
 291 
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 292 
Figure 5. Characterization of the Lac OCD in different E. coli strains. (a) Specific laccase activity 293 
measurements. (b) O2 consumption rate measurements using a Clark-type O2 electrode. Protein extracts were 294 
obtained from cells harboring the F2620 plus the Lac OCD (Lac OCD) and grown in M9 minimal medium 295 
supplemented with Cu2+. Cultures were induced in exponential phase and harvested 6 hours after induction 296 
with 10 µM AHL. Results were normalized per µg of protein. Error bars represent the standard deviation of 297 
biological replicates (n = 3), *** represents p-value <0.001. 298 
 299 
Basal levels of O2 consumption were detected for all strains even in the absence of 300 
inducer. The highest leakage was registered for the BL21 strain. This behavior was 301 
previously reported in the characterization of genetic logic gates38. The absence of the Lon 302 
protease, in the BL21 strain, results in reduced proteolysis and protein accumulation that 303 
may lead to crosstalk activation of the Plux promoter. Nevertheless, the on-off switching 304 
characteristics of the Lac OCD were maintained and, a significant increase in laccase 305 
activity and O2 consumption was observed for all strains. The highest fold increase 306 
(induced/control) was observed for Top10 and SURE, with 7-fold increase in laccase 307 
activity and 8- and 4-fold increase in O2 consumption, respectively. Since abiotic factors 308 
(such as medium and temperature) and also the component embedded sequence were 309 
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maintained, differences registered in the device performance are attributed to the strain 310 
specific genetic context. The DH5α, SURE, and Top10 strains display mutations that were 311 
introduced for molecular biology purposes and resulted in similar phenotypes. However, E. 312 
coli Top10 does not harbor the glnV44 and relA1 mutations, present in the SURE and 313 
DH5α strains, that enable RNA synthesis in absence of translation. Interestingly, this 314 
characterization demonstrates that the device performance is dependent on the genetic 315 
background, even in closely related strains. 316 
In vitro Performance of OCDs Based on Laccase-Variants. Additional OCDs, based on 317 
three laccase variants with improved activity and obtained through directed evolution C7 318 
(Leu170→Ser, Gly363→Glu, Glu476→Lys), E11 (Asp356→Glu, Asp380→Tyr), and H7 319 
(Met385→Ile, Gly436→Ser) (provided by Prof. Dan Tawfik, Weizmann Institute of 320 
Science, Israel), were assembled maintaining the context embedded sequence of the Lac 321 
OCD, using the F2620 BioBrick as regulatory element and the RBS BBa_B0034. These 322 
OCDs were characterized in vitro using protein extracts obtained from cells collected 6 323 
hours after the addition of the inducer AHL (Figure 6). Moreover, to gain insights on the 324 
location of the mutations in a 3D context, the protein structure of the variants was predicted 325 
by homology modelling with the CueO structure, using the online tool suite Phyre2.40 As 326 
previously mentioned, the CueO protein displays the MCOs typical T1 and T2/T3 copper 327 
centers, associated with substrate oxidation and oxygen reduction. This protein also has the 328 
unusual methionine-rich sequence with a helix that blocks the access of organic substrates 329 
to the T1 copper center and three additional copper binding sites essential for cuprous 330 
oxidase activity.30,39,41 331 
The characterization showed that the E11 variant does not have a significant 332 
improvement in performance (Figure 6). The two residues mutated in this variant, 333 
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Asp356→Glu, Asp380→Tyr, are part of CueO’s methionine- histidine-rich helical domain 334 
(Pro357-His406). The analysis of the mutational sensitivity, using the SuSPect tool,42 335 
revealed that mutations on residues 356 and 380 are unlikely to lead to alterations in protein 336 
performance as it was observed the in vitro assays performed in this work. The 3 mutations 337 
in the C7 variant (Leu170→Ser, Gly363→Glu, Glu476→Lys) resulted in a 2-fold increase 338 
in laccase activity but no significant improvement in terms of O2 consumption (Figure 6). 339 
The SuSPect analysis revealed that mutations of the 170 and 476 residues are likely to have 340 
a phenotypic effect and, from the protein structure it is possible to discern that these two 341 
residues are in the vicinity of the CueO domain interfaces, where the T1 Cu and the T2/T3 342 
trinuclear Cu centers are located. The third mutation in the 363 residue, located in the 343 
helical domain that covers the T1 Cu site, similarly to the mutations detected in the E11 344 
variant, has a low mutational sensitivity. Notably, the H7 variant exhibited a significant 345 
increase in performance with a 13-fold increase in laccase activity and 5-fold increase in O2 346 
consumption (Figure 6). Two mutations were detected in this protein, the 385 residue that 347 
is one of the methionines located in the methionine-histidine-rich helical domain, and the 348 
436 residue that it is in the vicinity of the Cu5, the T1 Cu ligands, and the hydrogen bond 349 
that connects them.26 Therefore, the increased performance displayed by this variant 350 
implies that the mutations are interfering with electron transfer route and/or with substrate 351 
access to the oxidation sites. 352 
 353 
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354 
Figure 6. Characterization of the OCD devices based on laccase variants in E. coli DH5α. (a) Specific laccase 355 
activity measurements. (b) O2 consumption rate measurements using a Clark-type O2 electrode. Protein 356 
extracts were obtained from cells harboring F2620 plus the Lac OCD (Lac OCD) and grown in M9 minimal 357 
medium supplemented with Cu2+. Cultures were induced with 10 µM AHL in exponential phase, and 358 
harvested 6 hours after induction. Results were normalized per µg of protein. Error bars represent the standard 359 
deviation of biological replicates (n = 3), *** represents p-value <0.001. 360 
 361 
In Vivo Performance of OCDs. To demonstrate the functionality of the OCDs in vivo, we 362 
started by performing a substrate screening since the substrate used for the in vitro assays – 363 
ABTS – can only be oxidized in acidic conditions. Different substrates known to be 364 
oxidized by laccase-like MCOs in neutral pH conditions were tested: syringaldazine, 2,6-365 
dimethoxyphenol (DMP), L-dihydroxyphenylalanine (L-DOPA), and tyrosine. In vitro, 366 
oxygen consumption was detected using syringaldazine, DMP, and L-DOPA. However, in 367 
vivo O2 consumption was observed only in presence of L-DOPA, probably because 368 
syringaldazine and DMP do not enter the cells. Therefore, L-DOPA was used as substrate 369 
to test the performance of the Lac and the H7 OCDs in vivo, using E. coli DH5α and Top10 370 
cells (Figure 7). A significant increase in O2 consumption associated to L-DOPA oxidation 371 
was detected in cells harboring the Lac OCD compared to the control (F2620), with a 100-372 
Page 18 of 33
ACS Paragon Plus Environment
ACS Synthetic Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
19 
 
fold increase registered for DH5α and 300-fold for Top10. However, this characterization 373 
revealed that the H7 variant does not show improved performance in vivo with L-DOPA 374 
(Figure 7). A similar result was obtained in vitro using the same substrate (Figure S6). 375 
These results are not surprising, since the improvement of the laccase by directed evolution 376 
was performed using ABTS as substrate. If indeed the H7 variant mutations facilitate 377 
substrate accessibility to the Type 1 Cu when higher molecular weight molecules (such as 378 
ABTS) are used, they have no effect when smaller molecules (like L-DOPA) are provided. 379 
The on-off switching characteristics of the device were not verified in vivo (Figure 7). This 380 
issue can be overcome by changing the regulatory element or abiotic factors such as 381 
temperature. Previous reports demonstrated that Plux promoter is leakier at 30 ºC than at 37 382 
ºC, suggesting that temperature can have an impact in the binding affinity between the 383 
operator sequence and the LuxR protein.38 384 
 385 
 386 
Figure 7. In vivo characterization of the Lac and H7 OCDs in E. coli DH5α and Top10. O2 consumption rates 387 
were measured using DH5α (left) or Top10 (right) cell suspensions grown in M9 medium supplemented with 388 
Cu2+ in control or induced conditions (presence or absence of AHL, respectively), and using L-DOPA as 389 
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substrate. Results were normalized per µg of protein. Error bars represent the standard deviation of biological 390 
replicates (n = 3). 391 
 392 
For further validation of the OCD functionality in vivo, E. coli Top10 cell 393 
suspensions were incubated in presence or absence of L-DOPA using sealed flasks and the 394 
dissolved O2 concentration was measured at different time-points (Figure S7). In cell 395 
suspensions incubated in the presence of L-DOPA the dissolved O2 is significantly reduced, 396 
representing 20-30% of the dissolved O2 in absence of the substrate (O2-saturated 397 
conditions). After 90 minutes of incubation, a similar concentration of dissolved oxygen in 398 
presence of L-DOPA or glucose (O2 consumed by respiration) was observed. These results 399 
demonstrate that O2 consumption by the synthetic OCD device is effectively able to 400 
modulate the dissolved oxygen concentration in cell suspensions. 401 
 402 
Conclusions. In this work, we were able to successfully demonstrate that OCDs based on 403 
E. coli’s native laccase CueO can be used to modulate intracellular O2 concentration. The 404 
assessment of devices based on CueO’s protein variants confirms the advantages of using a 405 
bacterial laccase, namely the possibility to improve its activity through protein engineering. 406 
In addition, and since laccases are broad range catalysts, the choice of substrate can be 407 
adapted to the chassis (genetic background) and the specific application envisaged. 408 
Furthermore, the OCDs robustness was attested by the hosts O2 consumption registered in 409 
all conditions tested. Interestingly, the devices were consistently functional in four of the 410 
five E. coli strains investigated but the performances were different, even in closely related 411 
strains. This work represents the proof of concept/stepping stone for the use of OCDs to 412 
elucidate or improve processes in micro-oxic/anoxic conditions and can be extended to 413 
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other bacterial chassis and specific applications. For example, coupling the OCD to a 414 
hydrogen producing device and an oxygen sensor, the latter already developed for the 415 
model cyanobacterium Synechocystis sp. PCC 6803,43 could establish a circuit for an 416 
efficient hydrogen production by this photoautotrophic chassis. The use of OCDs can also 417 
be applied to improve the production of alcohols (butanol, ethanol or propanol), glutamate, 418 
itaconate or 3-Hydroxybutyric acid by heterotrophic chassis, namely E. coli. The use of 419 
scaffolds may also be considered in applications that involve enzymes requiring a tight 420 
control of oxygen concentration. 421 
 422 
 423 
MATERIALS AND METHODS 424 
Chemicals. The M9 medium components, casamino acids and thiamine hydrochloride were 425 
obtained from BD Biosciences (SanJose, CA, USA) and VWR (Radnor, PA, USA), 426 
respectively. N-(β-ketocaproyl)-L-Homoserine lactone (3OC6HSL, AHL) was purchased 427 
from Santa Cruz Biotechnology (Dallas, TX, USA) and all other reagents from Sigma 428 
Aldrich (St. Louis, MO, USA) or Merck (Darmstadt, Germany). All DNA-modifying 429 
enzymes and polymerases were purchased from Thermo Fisher Scientific (Waltham, MA, 430 
USA). 431 
Strains and Media. For cloning purposes, Escherichia coli strain DH5α (Agilent, Santa 432 
Clara, CA, USA) was used and the transformants were cultivated at 37 ºC in lysogeny broth 433 
(LB)44, supplemented with 100 µg/mL ampicillin. 434 
The E. coli strains BL21(DE3) (Agilent), DH5α, MG1655 (E. coli genetic stock center, 435 
New Haven, CT, USA), SURE and Top10 (Invitrogen, Waltham, MA, USA) were used for 436 
the characterization of the laccase-based OCDs. Cell cultures were grown in M9 minimal 437 
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medium supplemented with 1 mM thiamine hydrochloride, 0.4% (vol/vol) glycerol, 0.2% 438 
(wt/vol) casamino acids, 2 mM MgSO4, 0.1 mM CaCl2 (M9),44 or in M9 supplemented 439 
with 20 µM CuSO4 (M9 Cu2+). Single colonies were inoculated into 5 mL M9 ampicillin 440 
(100 µg/mL) and grown overnight at 37 ºC with rotary shaking (120 rpm). Cultures were 441 
renewed and after overnight growth were used as inocula for the experiments. The cell 442 
cultures were grown in Erlenmeyer flasks maintaining a medium to headspace proportion 443 
of 1:4, the inocula were diluted to an initial OD600 of 0.05 and grown to the desired optical 444 
density. 445 
Selection of Protein Targets, Device Design and DNA Synthesis. The DESHARKY tool 446 
was used for the identification of pathways involving O2 consumption in Escherichia coli 447 
and Synechocystis sp. PCC 6803.31 The devices were designed based on the bioinformatics 448 
search outputs, in the BioBrick (BB) format (with Bb prefix and suffix), including the 449 
ribosome binding site (RBS) BBa_B0034 and the double terminator BBa_B0015 450 
(http://parts.igem.org).33 The Open Reading Frame (ORF) sequence from E. coli laccase 451 
(cueO) was codon optimized for E. coli K-12, Synechocystis sp. PCC 6803, and Nostoc sp. 452 
PCC 7120 using the software Gene Designer 2.0 (DNA 2.0, Menlo Park, CA, USA) to 453 
obtain a single sequence that could be potentially expressed in the three organisms. The 454 
DNA sequence comprising the BioBrick prefix, RBS, ORF, double terminator, and 455 
BioBrick suffix was synthesized by Epoch Life Science (Sugar Land, TX, USA). 456 
OCDs Assembly. For the generation of the Lac OCD, the composite Biobrick BBa_F2620 457 
(PtetR – luxR – PluxR) was assembled with the previously synthesized DNA sequence using 458 
the standard assembly protocol.33 Briefly, the vectors containing the codon optimized cueO 459 
ORF and the BBa_F2620 were digested with XbaI/PstI and SpeI/PstI, respectively. The 460 
DNA fragments were isolated from agarose gel or purified directly using the NZYGelpure 461 
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kit (NZYTech, Lisbon, Portugal), according to manufacturer’s instructions. Subsequently, 462 
the purified DNA fragments were ligated using the T4 DNA ligase. The Lac OCD construct 463 
was confirmed by restriction analysis and DNA sequencing (STAB VIDA, Lisbon, 464 
Portugal) using primers VF2 and VR (Table S1).45 465 
To obtain laccase protein variants a direct evolution approach was used (work 466 
carried out at Professor Dan Tawfik’s laboratory, Department of Biomolecular Sciences, 467 
Weizmann Institute of Science, Israel). For this purpose, a library of proteins was generated 468 
using the Megawhop method46 and subsequently screened using the phenoloxidase activity 469 
assay and ABTS as substrate (see In Vitro Assays below). For the assembly of the OCDs 470 
based on these laccase variants, the ORFs of the protein variants C7, E11, and H7 were 471 
amplified from the pGem®-T Easy (Promega, Madison, WI, USA), using the primers 472 
Bblac_F2 and Bblac_R2 that include the BioBrick™ prefix and suffix, respectively (Table 473 
S1). Each PCR mixture (20 µL) contained: 0.5 U of GoTaq Flexi DNA Polymerase 474 
(Promega), 1x GoTaq Flexi buffer, 200 µM of each deoxyribonucleotide triphosphate 475 
(dNTP), 1 µM of each primer, and 5 ng of template DNA. The PCR reaction profile was: 2 476 
min at 95 ºC followed by 25 cycles of 30 s at 95 ºC, 30 s at 50 ºC and 3 min at 72 ºC, and a 477 
final extension at 72 ºC for 7 min. The amplicons were purified, digested with XbaI/PstI 478 
and stepwise assembled with the BioBrick RBS part BBa_B0034 and then with the 479 
BBa_F2620 BioBrick, both digested with SpeI/PstI. The sequence of the three OCDs based 480 
on laccase protein variants were confirmed by DNA sequencing (STAB VIDA) using 481 
primers: VF2, VR, Ec_cueO_F and Ec_cueO_R (Table S1). 482 
Effect of the Lac OCD Induction on E. coli Growth. Cell cultures were grown until the 483 
early exponential phase (OD600 = 0.2-0.3) and, at this point, split into “control” and 484 
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“induced”. The latter received AHL (3OC6HSL) to a final concentration of 10 µM. The 485 
growth was monitored by measuring the OD600 every 2 hours for a 24 hours period. 486 
Sample Collection and Cell Extracts Preparation. For the collection of samples, cell 487 
cultures were grown in M9 or M9 Cu2+ media until the early exponential (OD600 = 0.2-0.3) 488 
or stationary (OD600 ≈ 2) phase. At these stages, the cultures were divided in two: one was 489 
induced by the addition of AHL (final concentration 10 µM) while the other served as 490 
control. Samples were collected at different time-points after induction (6, 12 or 24 hours) 491 
by centrifuging 20 mL of culture for 8 min at 4 500g, 4 ºC. The cell pellets were washed 492 
once using cold 50 mM phosphate buffer, pH 7.0 (KPi) and stored at -80 ºC until further 493 
use. 494 
For the preparation of cell extracts, the pellets were resuspended in 250 µL KPi 495 
containing protease inhibitors (Complete™ Mini EDTA-free Protease Inhibitor, Roche, 496 
Basel, Switzerland), that were added according to manufacturer’s instructions. Cells were 497 
then disrupted by sonication on ice with a Branson Sonifier 250 using 2 cycles of 15 s (50% 498 
dutty cycle, output 3) intercalated with 1 min off duty and then centrifuged for 8 min at 16 499 
000g, 4 ºC. The protein concentration of the extracts was measured using the BCA Protein 500 
Assay Kit (Thermo Scientific) according to the instructions. 501 
Confirmation of Protein Expression. Protein samples were separated by electrophoresis 502 
on SDS (sodium dodecyl sulfate)-polyacrylamide gels: in brief, electrophoresis was 503 
performed on a vertical mighty tall system (Hoefer, Holliston, MA, USA) according to the 504 
method of Laemmli.47 A 10% gel was prepared and samples, that were mixed with 505 
Laemmli sample buffer and heated at 95 ºC for 5 min, were loaded on the gel. Protein 506 
separation was carried out at 12 mA. After protein separation, proteins were visualized 507 
using Coomassie Brilliant Blue G250 (BIO-RAD, Hercules, CA, USA). 508 
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OCDs Characterization. 509 
In Vitro Assays. The phenol oxidase activity of the CueO multicopper oxidase (MCO) was 510 
measured using 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt 511 
(ABTS) as electron donor.48 Prior to the assay, the protein extracts were incubated with 1 512 
mM CuSO4 for 1 min and the appropriate volume of sample was added to the assay mixture 513 
in order to obtain linear oxidation kinetics. The assay mixture (500 µL) contained 50 mM 514 
sodium acetate buffer pH 5.0, protein extract (1-20 µL) and the reaction was started by the 515 
addition of ABTS to a final concentration of 3 mM. Substrate oxidation was monitored 516 
measuring the increase in A420 for 1 min at 30 ºC (ε420 = 36 000 L/mol.cm). The specific 517 
laccase activity was expressed as units of activity per µg of protein, where one activity unit 518 
represents one µmol of ABTS oxidized per min. 519 
The oxygen consumption rates were determined polarographically using a Clark-520 
type O2-electrode (Hansatech Instruments, Norfolk, UK). The assay previously described 521 
for phenol oxidase activity was performed using 1 mL working volume and a final 522 
concentration of 30 mM ABTS; oxygen uptake was expressed as nmol O2 consumed per 523 
min and normalized per µg of protein. 524 
For the screening of additional CueO substrates, the oxidation activities of 525 
syringaldazine, 2,6-dimethoxyphenol (DMP); L-dihydroxyphenylalanine (L-DOPA) and 526 
tyrosine were spectrophotometrically determined as described previously.49-51 The oxygen 527 
consumption measurements were performed using the same setup described for ABTS and 528 
10 mM syringaldazine, 20 mM L-DOPA and 20 mM DMP were used in the assays. 529 
In Vivo Assays. Cultures grown in absence or presence of AHL (inducer) and 12-24 h after 530 
induction were used. Cells were centrifuged for 8 min at 4 500g, 4 ºC and washed twice 531 
using cold 40 mM 3-(N-morpholino) propanesulfonic acid (MOPS) buffer pH 7.0. Finally, 532 
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cells were resuspended in MOPS buffer to a final OD600 ≈ 10 and kept on ice until 30 min 533 
before the assays, when cells were transferred to a water bath at 30 ºC. The assays were 534 
performed in 1 mL working volume containing 50 mM sodium phosphate buffer pH 6.0, 20 535 
mM L-DOPA and cells to a final OD600 = 1.0, 2.0 or 4.0. For the control of cell fitness an 536 
assay was performed using 20 mM glucose as substrate. The oxygen consumption rates 537 
were determined polarographically as described above, and expressed as nmol O2 538 
consumed per min and normalized per µg of protein. 539 
Online Tools and Statistical Analyses. To determine the likely success of sequence 540 
expression, the codon adaptation index (CAI) of the original and codon-optimized cueO 541 
sequences was calculated using the online tool CAICal.32 The E. coli K-12, Synechocystis 542 
sp. PCC 6803 and Nostoc sp. PCC 7120 codon usage tables used in the CAI calculations 543 
were retrieved from the Codon Usage Database (www.kazusa.or.jp/codon/). 544 
The relative codon adaptiveness values for the original and the codon optimized 545 
cueO sequences were obtained by the “each triplet position vs. usage table” method using 546 
the online graphical codon user analyzer and the E. coli K-12 codon usage table provided 547 
therein.52 548 
The online tool suite Phyre2 was used to predict the structure of the laccase protein 549 
variants by homology modelling with the CueO structure.40 The mutational sensitivity of 550 
protein residues was determined using the SuSPect tool42 also available in the Phyre2 551 
online tool suite. 552 
Data were expressed as mean values ± SD of at least three independent experiments. 553 
Values were compared by Student’s t-test and the 0.05 probability level was chosen as the 554 
point of statistical significance throughout. For the analysis of the factors affecting the 555 
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OCDs performance in vitro, a multi-way ANOVA was performed using the IBM SPSS 556 
software (Armonk, NY, USA). 557 
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Supporting Materials and Methods 
 
Table S1. Oligonucleotide used in this work. 
Primer name Sequence 5’ → 3’ Reference 
VF2 TGCCACCTGACGTCTAAGAA 
1 
VR ATTACCGCCTTTGAGTGAGC 
Bblac_F2* ACCATCGAATTCGCGGCCGCTTCTAGAGGATGCAACGTCGTG 
This work 
Bblac_R2* TCTTTACTAGTAGCGGCCGCTGCAGGGTTATACCGTAAACC 
Ec_cueO_F ATCAACCTGCCGCTACCTGC 
Ec_cueO_R TGTTGGCATGGTGGAAATCG 
*BioBrick prefix and suffix sequences are underlined and restriction sites highlighted in blue. 
(1) Shetty, R. P., Endy, D., and Knight Jr., T. F. (2008) Engineering BioBrick vectors from BioBrick 
parts. J Biol Eng 2, 5. 
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Supporting Figures 
 
 
Figure S1. Comparison of the codon adaptiveness of the codon optimized (blue line) and the original (red 
dashed line) cueO ORFs. Codon adaptiveness along the codon position in gene sequence is plotted. 
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Figure S2. Effect of the Lac OCD activation on E. coli BL21, MG1655, SURE and Top10 growth. The wild-
type (wt), the cells containing only the F2620 or F2620 plus the Lac OCD (Lac OCD) were grown in absence 
(C) or presence of the inducer (AHL). Growth was monitored measuring the OD600 every 2 hours for a 24 
hours period. Error bars represent the standard deviation of biological replicates (n = 3). 
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Figure S3. Characterization of the Lac OCD in E. coli DH5α cells grown in M9 medium. Specific laccase 
activity (a and c) and O2 consumption rate measurements (b and d) were performed using protein extracts 
obtained from cultures harboring the F2620 or the F2620 plus the Lac OCD (Lac OCD). Cultures were 
induced in exponential (top panel) or stationary phase (lower panel) and collected 6, 12 and 24 hours after 
induction. Cells were grown in the absence of inducer (control) or with 10 µM AHL (induced). The fold 
increase in O2 consumption (induced Lac OCD vs. induced F2620) at 6, 12 or 24 hours after induction is 
shown in b and d. Results were normalized per µg of protein. Error bars represent the standard deviation of 
biological replicates (n = 3). 
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Figure S4. Normalized GFP fluorescence of E. coli DH5α and MG1655 cultures harboring the F2620 
BioBrick + gfp. 96-well plates were setup using DH5α and MG1655 cultures (OD600 = 0.1) that were grown 
in the absence of inducer (control) or presence of 10 µM AHL (induced). Measurements were performed 0, 2, 
4, and 6 hours after plate setup and the fluorescence was normalized to Abs620. The results are representative 
of three biological replicates (with exception of MG1655 induced cultures, n = 10), with technical duplicates 
(measured in duplicate), error bars show ±S.D. 
  
8 
 
 
 
 
Figure S5. Characterization of the Lac OCD reassembled with the Ptrc1O promoter in E. coli DH5α and 
MG1655. Specific laccase activity was measured using protein extracts obtained from cells harboring the 
Ptrc1O or Ptrc1O plus the Lac OCD (Ptrc1O::cueO*) and grown in M9 minimal medium supplemented with Cu2+. 
Cultures were harvested 18 - 24 hours after inoculation. Results were normalized per µg of protein. Error bars 
represent the standard deviation of biological replicates (n = 4), *** represents p-value <0.001. 
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Figure S6. In vitro characterization of the Lac OCD in E. coli DH5α cells using L-DOPA as substrate. 
Specific laccase activity was measured using protein extracts obtained from the cultures used in the in vivo 
characterization. Cells harboring the F2620, the F2620 plus the Lac OCD (Lac OCD) or the F2620 plus the 
Lac H7 variant (H7 OCD) were grown in M9 medium supplemented with Cu2+ in control and induced 
conditions (presence or absence of AHL, respectively). Results were normalized per µg of protein. Error bars 
represent the standard deviation of biological replicates (n = 3), *** represents p-value <0.001. 
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Figure S7. Dissolved O2 measurements using E. coli Top10 suspensions incubated in sealed flasks. The cell 
suspensions were incubated with 30 mM L-DOPA (laccase substrate), 20 mM glucose (control for O2 
consumption) and 100 mM sodium bisulfite (Na bisulfite, control for O2-deprived conditions) at 37 °C with 
shaking. One mL samples were removed at different time points (0, 30, 45 and 90 min) using sterile syringes 
and needles; and the dissolved O2 concentration was measured using a Clark-type O2 electrode. Results were 
normalized to the dissolved O2 in saturated conditions (corresponding to 100% dissolved O2). Error bars 
represent the standard deviation of biological replicates (n = 2). 
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Supporting Methods 
GFP Fluorescence Analysis. For the evaluation of GFP expression, cultures of E. coli DH5α and 
MG1655 harboring the F2620 BioBrick or the F2620::gfp were grown overnight (final OD600 ≈ 3) in 
50 mL flasks at 37 °C with shaking (120 rpm). The cultures were diluted to a final OD600 ≈ 0.2 and 
100 µL aliquots were distributed in Nunc™ MicroWell™ 96-Well Optical-Bottom Plates (Thermo 
Fisher Scientific) containing 100 µL of M9 medium or M9 with 20 µM of AHL (to obtain a final 
concentration of 10 µM AHL in 200 µL). The 96-wells plates were incubated at 37 ºC with shaking 
(120 rpm), and measurements were carried out in duplicate 0, 2, 4 and 6 hours after plate setup. 
GFP fluorescence and Abs620 were detected using the Synergy 2 Multi-Mode Microplate Reader 
and the Gen5™ software (BioTek Instruments, Winooski, VT, USA). For fluorescence detection, an 
excitation filter of 485/20 nm and an emission filter of 528/20 nm were used (sensibility set for 
110). The experiments included 3 biological replicates, with the exception of MG1655 harboring 
the F2620::gfp for which 10 biological replicates were analyzed and technical duplicates were 
included for all samples. For data analysis, the background fluorescence and absorbance of the M9 
medium was subtracted from the values obtained for the samples and, the fluorescence values were 
normalized by optical density. 
Dissolved O2 Concentration Measurements Using Sealed Cultures. Cultures of E. coli Top10 
harboring the OCD (grown overnight) were washed and resuspended in 50 mM phosphate buffer, 
pH 7.0 (KPi) to a final OD600 ≈ 1.0. This cell suspension was distributed by different 4 Erlenmeyers 
(100 mL): the oxygen-saturated medium control (containing only cells), the oxygen-deprived 
medium control (cells + 100 mM sodium bisulfite) and the other two contained 20 mM L-DOPA 
(laccase substrate) or 20 mM glucose (used as O2 consumption control). The Erlenmeyer’s were 
sealed using Suba Seal rubber stoppers (Sigma), and were incubated at 37 °C with shaking. At 
different time points (0, 30, 45 and 90 min), 1 mL samples were removed through the stopper septa 
using a sterile syringes and needles and, the dissolved O2 concentration was measured using a 
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Clark-type O2-electrode (Hansatech Instruments). Results were normalized to the dissolved O2 in 
saturated conditions (corresponding to 100% dissolved O2). 
